GleamWall
中文EN

RMD RESMED INC

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 943819 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.0%
TTM net income YoY10.8%
TTM EPS YoY12.4%
Revenue 3-yr CAGR9.4%
Net income 3-yr CAGR20.7%

Margins

Gross margin61.1%
Operating margin33.0%
Net margin27.8%
FCF margin28.1%
EBITDA margin36.4%

Returns

ROE26.4%
ROA19.3%
ROIC (approx.)27.9%
Asset turnover0.69x

Leverage & solvency

Liabilities / assets27.6%
Debt / equity0.07x
Current ratio2.65x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.11x
Accruals ratio-2.2%
Payout ratio22.4%
Capex / revenue2.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-09-302026Q4*2026-06-302026Q32026-03-312026Q22025-12-312026Q12025-09-302025Q4*2025-06-302025Q32025-03-312025Q22024-12-31
Income statement
Revenue$1.41B$1.46B$1.43B$1.42B$1.34B$1.35B$1.29B$1.28B
Cost of revenue$544.25M$602.43M$540.43M$544.08M$517.92M$527.92M$525.33M$530.81M
Gross profit$870.57M$861.22M$890.98M$878.72M$817.66M$820.07M$766.41M$751.27M
R&D expense$102.86M$105.72M$94.27M$90.97M$89.48M$86.44M$83.94M$81.37M
SG&A expense$314.72M$296.28M$285.65M$278.40M$281.65M$265.12M$245.30M$241.61M
Operating income$452.98M$448.71M$499.81M$491.66M$446.54M$454.54M$426.27M$417.24M
Interest expense$4.81M———$7.12M———
Pretax income$539.15M$474.16M$502.31M$496.15M$446.79M$458.05M$417.69M$418.32M
Income tax$120.74M$90.73M$103.58M$103.56M$98.26M$78.35M$52.65M$73.70M
Net income$418.41M$383.43M$398.73M$392.59M$348.54M$379.70M$365.04M$344.62M
EBITDA$494.73M$493.49M$558.79M$541.54M$494.24M$518.17M$469.94M$463.68M
EPS (basic)2.93—2.742.692.38—2.492.35
EPS (diluted)2.92—2.742.682.37—2.482.34
Dividends declared per share0.660.600.600.600.600.530.530.53
Weighted avg. shares (diluted)143.41M—145.72M146.37M146.90M—147.22M147.48M
Balance sheet
Cash & equivalents$1.01B$1.47B$1.66B$1.42B$1.38B$1.21B$932.71M$521.94M
Receivables$972.50M$1.04B$998.84M$985.63M$907.27M$939.49M$907.83M$859.94M
Inventory$1.02B$945.80M$911.88M$922.04M$945.81M$927.71M$862.64M$882.10M
Current assets$3.51B$4.32B$4.06B$3.82B$3.63B$3.51B$3.21B$2.84B
PP&E, net$601.79M$581.83M$566.97M$564.25M$563.63M$550.79M$535.34M$520.16M
Goodwill$2.91B$2.91B$3.04B$3.04B$3.04B$3.05B$2.85B$2.81B
Intangibles$442.68M$452.74M$425.19M$430.24M$447.07M$464.86M$430.11M$438.00M
Total assets$8.21B$8.97B$8.78B$8.50B$8.31B$8.17B$7.57B$7.14B
Current liabilities$1.32B$1.40B$1.35B$1.25B$1.26B$1.02B$940.52M$851.96M
Short-term debt$159.97M$259.95M$259.93M$259.91M$259.90M$9.90M$9.91M$9.91M
Long-term debt$249.63M$399.42M$404.17M$403.92M$408.66M$658.39M$663.13M$662.86M
Total debt$409.60M$659.37M$664.10M$663.83M$668.56M$668.29M$673.03M$672.76M
Total liabilities$2.26B$2.38B$2.29B$2.18B$2.19B$2.21B$2.02B$1.89B
Shareholders' equity$5.95B$6.59B$6.49B$6.32B$6.12B$5.97B$5.55B$5.25B
Net debt-$601.14M-$809.87M-$996.42M-$753.24M-$715.29M-$541.16M-$259.68M$150.82M
Shares outstanding140.64M144.24M145.04M145.66M145.94M146.39M146.62M146.86M
Cash flow statement
Operating cash flow$422.42M$454.63M$554.13M$339.75M$457.32M$538.77M$578.66M$308.62M
Capital expenditure$48.74M$51.13M$33.65M$28.54M$42.97M$30.59M$20.80M$20.64M
Free cash flow$373.68M$403.50M$520.48M$311.21M$414.36M$508.18M$557.87M$287.98M
Investing cash flow$392.06M-$383.65M-$58.03M-$50.94M-$52.58M-$133.71M-$31.79M-$36.69M
Financing cash flow-$1.28B-$263.16M-$255.24M-$258.35M-$230.27M-$163.89M-$144.07M-$147.54M
Depreciation & amortization$41.74M$44.78M$58.98M$49.88M$47.70M$63.63M$43.67M$46.44M
Stock-based compensation$29.48M$27.46M$26.79M$28.94M$21.16M$24.75M$24.12M$22.63M
Dividends paid$94.95M$87.09M$87.24M$87.58M$87.75M$77.59M$77.70M$77.69M
Share buybacks$936.38M$200.00M$175.01M$175.01M$150.01M$100.01M$75.03M$74.99M

Free plan shows the latest 8 periods; Pro shows all 69 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.